I meant "maybe Fiona Stanley are so impressed with phase 2 they will push for next phase asap due to unmet need."
It would also be valuable I think if Recce refer directly to the QIDP and or FDA regarding future progress or plans at some stage.
Hard to believe they just plan to sell this product in Australia but would be good to get official confirmation FDA is a target for either or both IV and burns? At this stage there still appear to be some who think they have decided against this path.
I'm looking forward to seeing where this goes .
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-104
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.015(3.03%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 47.5¢ | $15.27K | 31.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9911 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 2577 | 1 |
View Market Depth
| Last trade - 15.48pm 02/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |